Journal of Gynecologic Oncology

Article	Citations
Clinical practice guidelines for cervical cancer: an update of the Korean Society of Gynecologic Oncology Guidelines	89
Circ_0075960 targets the miR-202-5p/CTNND1 axis to promote the growth and migration of endometrial carcinoma cells via regulating Wnt/β-catenin signaling activity	38
Prognostic significance of para-aortic node metastasis in endometrial cancer: Japanese Gynecologic Oncology Group Study JGOG2043 post hoc analysis	30
Step-by-step demonstration of “sciatic-nerve-preserved beyond-LEER” in a Thiel-embalmed cadaver: a novel salvage surgery for recurrent gynecologic malignancies	26
The efficacy of the levonorgestrel intrauterine system versus oral megestrol acetate in treating atypical endometrial hyperplasia: a superior randomized controlled trial	26
Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles	25
Nomogram for predicting pathology upstaging in patients with EIN: is sentinel lymph node assessment useful in these patients?	23
Para-aortic lymph node dissection with or without nerve-sparing in gynecological malignancies	23
Comparison of postoperative adjuvant platinum-based chemotherapy and no further therapy after radical surgery in intermediate-risk early-stage cervical cancer	23
Impact of adjuvant chemotherapy on the overall survival of patients with resectable bulky small cell neuroendocrine cervical cancer: a JSGO-JSOG joint study	23
A predictive model for lymph node metastasis using tumor location in presumed early-stage endometrioid endometrial cancer patients	20
Risk factors for lower extremity lymphedema after surgery in cervical and endometrial cancer	19
Phase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency (JGOG2052)	16
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT)	15
Prognostic influence of an early time to chemotherapy following primary cytoreductive surgery for advanced epithelial ovarian cancer	15
Effect of adjuvant treatment on survival in 2023 FIGO stage IIC endometrial cancer	14
Surgical technique of two-step pelvic and para-aortic sentinel lymph node mapping in early-stage endometrial cancer: laparoscopic, robotic, and open method	14
Author's reply to: Effect of adjuvant treatment on survival in 2023 FIGO stage IIC endometrial cancer	14
Evaluation of secondary cytoreduction surgery in platinum-resistant ovarian cancer patients within three-line recurrent: a multicenter, randomized controlled study	14
Laparoscopic radical hysterectomy without uterine manipulator or vaginal tube use	14
Comparison of survival outcomes between robotic and laparoscopic radical hysterectomies for early-stage cervical cancer: a systemic review and meta-analysis	13
Posterior pelvic exenteration for ovarian cancer: surgical and oncological outcomes	13
ASGO 7th International Workshop on Gynecologic Oncology	13
Missing a chance to prevent: disparities in completion of genetic evaluation in high-risk patients with endometrial cancer	12
Prognosis in primary mucinous ovarian carcinoma: focusing on the five pathological findings indicating metastatic mucinous carcinoma to the ovary	11

Associations between obesity, metabolic syndrome, and endometrial cancer risk in East Asian women	11
HPV vaccination among seropositive, DNA negative cohorts: a systematic review & meta-analysis	11
Circular RNA intraflagellar transport 80 facilitates endometrial cancer progression through modulating miR-545-3p/FAM98A signaling	10
Efficacy of lymph node dissection on stage IIICr of cervical cancer before CCRT: study protocol for a phase III, randomized controlled clinical trial (CQGOG0103)	10
Improving the efficacy and safety of concurrent chemoradiotherapy by neoadjuvant chemotherapy: a randomized controlled study of locally advanced cervical cancer with a large tumor	10
Comparison of treatment outcomes of surgery and radiotherapy, including concurrent chemoradiotherapy for stage Ib2-IIb cervical adenocarcinoma patients: a retrospective study	10
Cervical cancer patient reported gastrointestinal outcomes: intensity/volumetric modulated vs. 3D conformal radiation therapy	10
Feasibility, accuracy and acceptability of self-sampled human papillomavirus testing using careHPV in Cambodia: a cross-sectional study	10
Incidence and treatment outcomes of uterine cervical cancer in Korea 1999–2018 from the national cancer registry	9
Evaluation of CD4+ cells infiltration as a prognostic factor in cervical intraepithelial neoplasia 2	9
Predicting prognosis according to the updated WHO classification in patients with endocervical adenocarcinoma treated with surgery and radiotherapy	9
Trends in cervical cancer screening rates among Korean women: results of the Korean National Cancer Screening Survey, 2005–2020	9
Number of FoxP3+ regulatory T-cells are associated with recurrence in vulvar squamous cell carcinoma	9
Adherence of PARP inhibitor for frontline maintenance therapy in primary epithelial ovarian cancer: a cross-sectional survey	9
Recent breakthroughs in the management of locally advanced and recurrent/metastatic cervical cancer	8
Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey	8
Increased cardiovascular disease risk among adolescent and young adult survivors of cervical cancer	8
Cause-specific mortality rate of ovarian cancer in the presence of competing risks of death: a nationwide population-based cohort study	8
Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study	7
An attempt to establish real-world databases of poly(ADP-ribose) polymerase inhibitors for advanced or recurrent epithelial ovarian cancer: the Japanese Gynecologic Oncology Group	7
Optimal number of neoadjuvant chemotherapy cycles prior to interval debulking surgery in advanced epithelial ovarian cancer: a systematic review and meta-analysis of progression-free survival and over	7
The 8th Biennial Meeting of the Asian Society of Gynecologic Oncology, December 1st to 3rd, 2023	7
The pathologic and clinical outcomes of risk-reducing salpingo-oophorectomy in asymptomatic carriers of homologous recombination repair gene mutation	7
Practice guideline for management of endometrial cancer in Thailand: a Thai Gynecologic Cancer Society consensus statement	7
Minimally invasive radical hysterectomy and the importance of avoiding cancer cell spillage for early-stage cervical cancer: a narrative review	7
Bevacizumab in frontline chemotherapy improved the survival outcome for advanced ovarian clear cell carcinoma: a multicenter retrospective analysis	7
Parametrial involvement and decreased survival of women with FIGO stage IIIC1 cervical cancer	6
PLIN2: a potential prognostic markers of early-stage atypical endometrial hyperplasia	6
Attitudes toward subsequent primary cancer prevention among survivors of childhood, adolescent, and young adult (CAYA) cancer in Japan: results of a comprehensive questionnaire survey on long-term wom	6
RB1 alteration and poor prognosis in women with high-grade neuroendocrine carcinoma of the uterine cervix: a NeCTuR study	6
Knowledge and awareness of cervical cancer and prevention measures among female students in Poland: a cross-sectional, decade apart study	6
Revision of quality indicators for cervical cancer and trend analysis of existing indicators in Japan	6
Adjuvant chemotherapy after radical hysterectomy yields comparable outcomes to chemoradiation for stage IB2-IIB and IIIC1-2 cervical cancer: a single-center retrospective study	6
Addendum: A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study	6
Diagnostic performances of the Ovarian Adnexal Reporting and Data System, the Risk of Ovarian Malignancy Algorithm, and the Copenhagen Index in the preoperative prediction of ovarian cancer: a prospec	5
Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines	5
Relacorilant plus nab-paclitaxel for recurrent, platinum-resistant ovarian cancer: a cost-effectiveness study	5
Reviewer recognition in 2021	5
Expert commentary on HORSE/MITO18 and CHIPOR	5
Author's reply to: Cisplatin versus carboplatin?	5
Patient-reported symptom burden and circulating cytokines undergoing chemotherapy: a pilot study in patients with ovarian cancer	5
Total mesometrial resection (TMMR) for cervical cancer FIGO IB–IIA: first results from the multicentric TMMR register study	5
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician’s choice chemotherapy in patients with previously treated advanced or recurrent end	5
Outcomes of extended progestin therapy in atypical endometrial hyperplasia patients without an initial response to progestin: a retrospective study from two tertiary centers in Korea and Taiwan	5
HIPEC in recurrent ovarian cancer: flogging a tired HORSE?	5
Clinical outcome and pattern of care for isolated or incidental serous tubal intraepithelial carcinoma: a multicenter retrospective cohort study	5
Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome	5
Improved bladder function in radical hysterectomy without worsening oncologic outcome: resection of the posterior layer of the vesicouterine ligament with the procedure limited to the vesical veins	4
Correspondence on: The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter by Nicolai et al.	4
Rotational intraperitoneal pressurized aerosol chemotherapy with paclitaxel and cisplatin: pharmacokinetics, tissue concentrations, and toxicities in a pig model	4

Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle-income country setting	4
Efficacy of edoxaban for the treatment of gynecological cancer-associated venous thromboembolism: analysis of Japanese real-world data	4
The 7th Biennial Meeting of the Asian Society of Gynecologic Oncology, November 25th to 27th, 2021	4
Effectiveness and safety of nab-paclitaxel and platinum as first-line chemotherapy for ovarian cancer: a retrospective study	4
Elucidation of genomic origin of synchronous endometrial and ovarian cancer (SEO) by genomic and microsatellite analysis	4
Bispecific immunotherapy MEDI5752 or volrustomig and cervical cancer	4
Novel vaginoplasty technique involving the use of peritoneal flaps during laparoscopic radical hysterectomy for early-stage cervical cancer	4
A novel gene signature associated with poor response to chemoradiotherapy in patients with locally advanced cervical cancer	4
Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications	4
First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial	4
Perioperative outcomes and platinum resistant recurrence in patients undergoing systematic, protocol-based, total parietal peritonectomy during interval cytoreductive surgery for advanced ovarian canc	4
Diagnostic significance and predictive efficiency of metabolic risk score for fertility-sparing treatment in patients with atypical endometrial hyperplasia and early endometrial carcinoma	4
Functions, interactions and prognostic role of POLE: a bioinformatics analysis	4
Genomic landscape of advanced endometrial cancer analyzed by targeted next-generation sequencing and the cancer genome atlas (TCGA) dataset	4
Cost-effectiveness of tisotumab vedotin as a second- or third-line therapy for cervical cancer	4
Survival benefits of retroperitoneal lymphadenectomy for optimally-resected advanced ovarian high-grade serous carcinoma: a multi-institutional retrospective study	4
CircSMAD2 accelerates endometrial cancer cell proliferation and metastasis by regulating the miR-1277-5p/MFGE8 axis	3
Predictors of postoperative pancreatic fistula after splenectomy with or without distal pancreatectomy performed as a component of cytoreductive surgery for advanced ovarian cancer	3
Diagnostic performance of microRNA-34a, let-7f and microRNA-31 in epithelial ovarian cancer prediction	3
Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy	3
Prognostic factors of adult granulosa cell tumors of the ovary: a Turkish retrospective multicenter study	3
Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer	3
Clinical practice guidelines for uterine corpus cancer: an update to the Korean Society of Gynecologic Oncology guidelines	3
Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: a prospective,	3
Current peritonectomy practice during debulking surgery in patients with newly diagnosed advanced ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 4004)	3
Bone health after RRBSO among BRCA1/2 mutation carriers: a population-based study	3
Salvage hysterectomy for persistent residual cervical cancer: assessment of prognostic factors	3
Revisiting the meaning of Trousseau sign and syndrome	3
Fertility-sparing treatment outcomes using immune checkpoint inhibitors in endometrial cancer patients with Lynch syndrome	3
Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review	3
Unveiling pembrolizumab effectiveness in diverse subtypes of MSI-high endometrial cancers	3
Epidemiologic study on gestational trophoblastic diseases in Japan	3
Evaluation of the role of liver metastasectomy in the treatment of stage IV endometrial cancer	3
Effectiveness of craniotomy and long-term survival in 35 patients with gestational trophoblastic neoplasia with brain metastases: a clinical retrospective analysis	3
The automatic diagnosis artificial intelligence system for preoperative magnetic resonance imaging of uterine sarcoma	3
A phase II, open-label, non-randomized, prospective study assessing paclitaxel, carboplatin and metformin in the treatment of advanced stage ovarian carcinoma	3
Erratum: Closing the gap for cervical cancer research in Vietnam: current perspectives and future opportunities: a report from the 5th Gynecologic Cancer InterGroup (GCIG) Cervical Cancer Research Net	3
Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III epithelial OVArian, fallopian tube and primary per	3
Reviewer recognition in 2023	2
Clinicopathologic and protein markers distinguishing the “polymerase epsilon exonuclease” from the “copy number low” subtype of endometrial cancer	2
Genetic analysis of cervical cancer with lymph node metastasis	2
PARPis response and outcome of ovarian cancer patients with BRCA1/2 germline mutation and a history of breast cancer	2
Mirvetuximab soravtansine in platinum-resistant recurrent ovarian cancer with high folate receptor-alpha expression: a cost-effectiveness analysis	2
Gynecologic oncology in 2024: breakthrough trials and evolving treatment strategies for cervical, uterine corpus, and ovarian cancers	2
Cervical screening among Chinese females in the era of HPV vaccination: a population-based survey on screening uptake and regular screening following an 18-year organized screening program	2
Prognostic significance of heterologous component in carcinosarcoma of the gynecologic organs: a systematic review and meta-analysis	2
The 1st annual meeting of the East Asian Gynecologic Oncology Trial Group (EAGOT)	2
Olaparib plus bevacizumab as a first-line maintenance treatment for patients with advanced ovarian cancer by molecular status: an updated PAOLA-1 based cost-effectiveness analysis	2
Reviewer recognition in 2022	2
Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis: comment	2
The 1st Indonesian Society Gynecologic Oncology Scientific Meeting (INASMEET), November 12th to November 13th, 2022	2
Integrated analysis of DNA methylome and transcriptome reveals SFRP1 and LIPG as potential drivers of ovarian cancer metastasis	2
Real-world efficacy and safety of bevacizumab single-maintenance therapy following platinum-paclitaxel chemotherapy plus bevacizumab in patients with advanced cervical cancer	2
A phase 1/2a, dose-escalation, safety, and preliminary efficacy study of the RKP00156 vaginal tablet in healthy women and patients with cervical intraepithelial neoplasia 2	2
Mutations in homologous recombination repair genes in patients with metastatic endometrial cancer: association with clinical characteristics and prognosis	2
Prophylactic salpingectomy as a preventative strategy for ovarian cancer in the general population: a systematic review and meta-analysis	2
Patient and clinician priorities for information on treatment outcomes for advanced ovarian cancer: a Delphi exercise	2
An update of oncologic and obstetric outcomes after abdominal trachelectomy using the FIGO 2018 staging system for cervical cancer: a single-institution retrospective analysis	2
Selective utilization of circulating tumor DNA testing enables disease monitoring in endometrial and ovarian carcinomas	2
Frequency and clinical features of deficient mismatch repair in ovarian clear cell and endometrioid carcinoma	2
Laparoscopic resection surgery for malignant transformation of extragonadal endometriosis by the “pincer” approach	2
Comprehensive characterization of genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC: a single center experience	2
Informed consent forms for gynecologic cancer surgery: recommendations from the Korean Society of Gynecologic Oncology	2
Where is ERAS in the management of advanced ovarian cancer?: between myths and truths	2
Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: a survey by the Gynecologic Oncology Committee of the Japan Society of O	2
Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multice	2
A multimodal intervention program to improve sexual health and self-perceived quality of life in patients treated for cervical cancer: a randomized prospective study (PROVIDENCE trial)	2
Contrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage epithelial ovarian cancer in Australia, South Korea and Taiwan	2
A step towards the ambition of precision oncology in recurrent ovarian cancer	2
Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology consensus statement	2
The impact of cytoreductive surgery on outcomes in high tumor burden ovarian cancer after induction of PARP inhibitors	2
Response to: Author's reply to: Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002)	2
Immunotherapy plus chemotherapy in patients with advanced endometrial cancer: a cost-effectiveness analysis	1
Transabdominal cardiophrenic lymph node dissection for cytoreductive surgery in advanced ovarian cancer	1
Outcomes and prognostic factors of surgically treated extramammary Paget’s disease of the vulva	1
SLAMF7 predicts prognosis and correlates with immune infiltration in serous ovarian carcinoma	1
CHIPOR, HORSE, and beyond: unraveling the role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer	1
Evaluating the specific STAT3 inhibitor YHO-1701 in ovarian cancer cell lines and patient-derived cell models: efficacy, mechanisms, and therapeutic potential	1
Predictive factors of surgical complications after pelvic exenteration for gynecological malignancies: a large single-institution experience	1
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer	1

Clinicopathological and molecular characterization of high-grade endometrial carcinoma with POLE mutation: a single center study	1
A retrospective study of dose-dense paclitaxel and carboplatin plus bevacizumab as first-line treatment of advanced epithelial ovarian cancer	1
TP53 variants in p53 signatures and the clonality of STICs in RRSO samples	1
Author's reply to: Revisiting the meaning of Trousseau sign and syndrome	1
Japan Society of Gynecologic Oncology 2022 guidelines for uterine cervical neoplasm treatment	1
Lymphocyte activation gene (LAG)-3 is a potential immunotherapeutic target for microsatellite stable, programmed death-ligand 1 (PD-L1)-positive endometrioid endometrial cancer	1
Posterior pelvic exenteration, a crucial component in the surgeon’s toolbox for optimizing surgical cytoreduction for advanced ovarian cancer	1
Preoperative serum microRNAs as potential prognostic biomarkers in ovarian clear cell carcinoma	1
Low-grade endometrial stromal sarcoma with intravenous thrombus extension: a multidisciplinary surgical challenge	1
Reconstruction of the diaphragm with autologous fascia lata during cytoreduction in patients with advanced ovarian cancer	1
Targeting BRAF pathway in low-grade serous ovarian cancer	1
Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-ov80)	1
Study of neoadjuvant chemotherapy in advanced malignant ovarian germ cell tumors at a tertiary center in western India	1
Immunosensitivity and specificity of insulinoma-associated protein 1 (INSM1) for neuroendocrine neoplasms of the uterine cervix	1
Airborne and surface contamination after rotational intraperitoneal pressurized aerosol chemotherapy using cisplatin	1
Investigation of selective glucocorticoid receptor modulation in high-grade serous ovarian cancer PDX models	1
Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: an	1
Trends in the incidence and survival outcomes of endometrial cancer in Korea: a nationwide population-based cohort study	1
Diagnostic accuracy and prognostic factors of uterine serous carcinoma in Japanese women: a multi-center study	1
East Asian Gynecologic Oncology Trial Group (EAGOT): founding history and future perspective	1
Efficacy of intra-abdominal cytoreductive surgery in advanced endometrial cancer with distant metastasis	1
An evaluation of prognostic factors, oncologic outcomes, and management for primary and recurrent squamous cell carcinoma of the vulva	1
Role of HPV E7/miR-143-3p/SH2D3A pathway in regulating the occurrence and development of cervical cancer	1
The course forward: next generation sequencing as part of the next generation management of patients with locally advanced cervical cancer	1
Supragastric lesser sac: an insidious site for surgical exploration during the debulking surgery in advanced ovarian cancer	1
Implementation rate and related factors of confirmatory tests following an abnormal Pap smear: a nationwide study from the National Health Insurance	1
RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma	1
Prognostic values of tumor size and location in early stage endometrial cancer patients who received radiotherapy	1
Clinical evaluation of a droplet digital PCR assay for detecting POLE mutations and molecular classification of endometrial cancer	1
Identification of the prognostic immune subtype in copy-number high endometrial cancer	1
Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial	1
Incidence and risk factors for the development of cerebral metastasis in cervical cancer patients	1
One-step nucleic acid amplification (OSNA) assay for detecting lymph node metastasis in cervical and endometrial cancer: a preliminary study	1
HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcoma	1
Clinical practice guidelines for ovarian cancer: an update to the Korean Society of Gynecologic Oncology guidelines	1
Clinicopathological features and patterns of treatment of patients with endometrial cancer in Brazil	1
Ovarian squamous cell carcinoma: clinicopathological features, prognosis and immunotherapy outcomes	1
The prognosis impact of NACT-IDS and PDS in advanced ovarian cancer: a systematic review and meta-analysis	1
The impact of interval between primary cytoreductive surgery with bowel resection and initiation of adjuvant chemotherapy on survival of women with advanced ovarian cancer: a multicenter cohort study	1
Risk factors for and delayed recognition of genitourinary fistula following radical hysterectomy for cervical cancer: a population-based analysis	1
Anti-cancer effect of fenbendazole-incorporated PLGA nanoparticles in ovarian cancer	1
CDK1 promotes the phosphorylation of KIFC1 to regulate the tumorgenicity of endometrial carcinoma	1
The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women’s cancer research organization	1
Significance of HPV status on tumor response and treatment outcomes in endocervical adenocarcinoma treated with definitive chemoradiotherapy: a retrospective study	1
Prevention of symptomatic pulmonary embolism for gynecologic malignancies with preoperative asymptomatic venous thromboembolism: GOTIC-VTE trial	1
Significance of histology and nodal status on the survival of women with early-stage cervical cancer: validation of the 2018 FIGO cervical cancer staging system	1
Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)	1
Impact of peritoneal vaginoplasty combined with radical hysterectomy on the quality of sexual life for patients with early-stage cervical cancer: trial protocol for a multi-center superiority randomiz	1
Comparison of the safety between cervical conization and hysterectomy for patients with cervical adenocarcinoma in situ	1
Enrichment for the POLE mutated against p53 wild subtype using clinicopathologic factors and cyclin B1 immunohistochemistry in endometrial cancer	1
Therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer IIICr: a trial protocol for a phase III, multicenter, randomized controlled study (KGOG1047/DEBULK trial)	1
A prospective comparison of the diagnostic accuracies of ultrasound and magnetic resonance imaging in preoperative staging of endometrial cancer	1
AP2α negatively regulates PDHA1 in cervical cancer cells to promote aggressive features and aerobic glycolysis in vitro and in vivo	1
Efficacy and safety of cisplatin combined with paclitaxel concurrent radiotherapy in patients with locally advanced cervical squamous cell carcinoma	1
Impact of COVID-19 on gynecologic cancer treatment in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)	1
Levonorgestrel-releasing intrauterine system-based therapies for early-stage endometrial cancer: a systematic review and meta-analysis	1
PRIMA: captivated by the wizard of OS?	1